Status:
RECRUITING
PRO Survivorship Concerns ITA
Lead Sponsor:
Regina Elena Cancer Institute
Collaborating Sponsors:
Centro di Riferimento Oncologico - Aviano
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale
Conditions:
Breast Neoplasm Female
Quality of Life
Eligibility:
FEMALE
18+ years
Brief Summary
Breast cancer survivors typically experience fatigue, pain, insomnia, depression, anxiety, difficulty in concentrating, memory impairment, body image problems, vaginal dryness, interest in sex decreas...
Eligibility Criteria
Inclusion
- During transcultural adaptability 80 representative patients will be recruited .
- During the validation phase previus patients will be included and more other patients will be included (at least 280)
Exclusion
- Patients with cognitive or memory impairment wil be excluded
Key Trial Info
Start Date :
January 18 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 18 2024
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT06080607
Start Date
January 18 2022
End Date
June 18 2024
Last Update
March 25 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Regina Elena Cancer Institute
Rome, Roma, Italy, 00144
2
"Regina Elena" National Cancer Institute
Rome, Italy, 00144